CLINIMED: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CLINIMED
Largest movements
- Receivables within one year +€14,819
up €14,819 (+595.7%), from €2,488 to €17,307
of which Other amounts receivable: +€14,766
- Tangible fixed assets -€14,192
down €14,192 (-37.9%), from €37,445 to €23,253
of which Furniture and vehicles: -€12,745
- Cash -€13,909
down €13,909 (-11.3%), from €122,755 to €108,847
mainly Contributions, distributions and other (-€190,000) and Receivables within one year (-€14,819)
- Profit (loss) carried forward -€97,533
down €97,533 (-77.4%), from €126,037 to €28,504
- Other debts +€88,318
up €88,318 (+17913.2%), from €493 to €88,811
- Tax, wage and social debts +€24,075
up €24,075 (+544.1%), from €4,425 to €28,500
of which Taxes: +€24,075
- Trade debts -€13,099
down €13,099 (-100.0%), from €13,099 to €0
- Debts after one year -€10,699
down €10,699 (-100.0%), from €10,699 to €0
- Gross operating margin +€20,122
up €20,122 (+17.0%), from €118,638 to €138,760
- Taxes +€10,834
up €10,834 (+50.4%), from €21,512 to €32,346
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €171,468 | €158,409 | -€13,060 | -7.6% |
| Fixed assets | 21/28 | €41,986 | €27,794 | -€14,192 | -33.8% |
| Tangible fixed assets | 22/27 | €37,445 | €23,253 | -€14,192 | -37.9% |
| Plant, machinery and equipment | 23 | €4,287 | €2,840 | -€1,448 | -33.8% |
| Furniture and vehicles | 24 | €33,158 | €20,414 | -€12,745 | -38.4% |
| Financial fixed assets | 28 | €4,541 | €4,541 | = | 0.0% |
| Current assets | 29/58 | €129,482 | €130,614 | +€1,132 | +0.9% |
| Amounts receivable within one year | 40/41 | €2,488 | €17,307 | +€14,819 | +595.7% |
| Trade receivables | 40 | - | €53 | +€53 | |
| Other amounts receivable | 41 | €2,488 | €17,254 | +€14,766 | +593.6% |
| Cash at bank and in hand | 54/58 | €122,755 | €108,847 | -€13,909 | -11.3% |
| Deferred charges and accrued income | 490/1 | €4,239 | €4,461 | +€222 | +5.2% |
| Total equity and liabilities | 10/49 | €171,468 | €158,409 | -€13,060 | -7.6% |
| Equity | 10/15 | €127,037 | €29,504 | -€97,533 | -76.8% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €126,037 | €28,504 | -€97,533 | -77.4% |
| Amounts payable | 17/49 | €44,431 | €128,904 | +€84,473 | +190.1% |
| Amounts payable after more than one year | 17 | €10,699 | €0 | -€10,699 | -100.0% |
| Financial debts | 170/4 | €10,699 | €0 | -€10,699 | -100.0% |
| Amounts payable within one year | 42/48 | €33,732 | €128,904 | +€95,172 | +282.1% |
| Current portion of amounts payable after more than one year | 42 | €15,715 | €10,699 | -€5,017 | -31.9% |
| Financial debts | 43 | - | €895 | +€895 | |
| Other loans | 439 | - | €895 | +€895 | |
| Trade debts | 44 | €13,099 | €0 | -€13,099 | -100.0% |
| Suppliers | 440/4 | €13,099 | €0 | -€13,099 | -100.0% |
| Taxes, remuneration and social security | 45 | €4,425 | €28,500 | +€24,075 | +544.1% |
| Taxes | 450/3 | €4,425 | €28,500 | +€24,075 | +544.1% |
| Remuneration and social security | 454/9 | €0 | - | = | |
| Other amounts payable | 47/48 | €493 | €88,811 | +€88,318 | +17913.2% |
| Accrued charges and deferred income | 492/3 | €0 | - | = | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €14,929 | €14,192 | -€737 | -4.9% |
| Other operating charges | 640/8 | €939 | €460 | -€479 | -51.0% |
| Gross operating margin | 9900 | €118,638 | €138,760 | +€20,122 | +17.0% |
| Operating profit (loss) | 9901 | €102,770 | €124,108 | +€21,338 | +20.8% |
| Financial income | 75/76B | €745 | €1,549 | +€804 | +107.9% |
| Recurring financial income | 75 | €745 | €1,549 | +€804 | +107.9% |
| Financial charges | 65/66B | €1,316 | €844 | -€471 | -35.8% |
| Recurring financial charges | 65 | €1,316 | €844 | -€471 | -35.8% |
| Profit (loss) for the period before taxes | 9903 | €102,199 | €124,813 | +€22,614 | +22.1% |
| Income taxes | 67/77 | €21,512 | €32,346 | +€10,834 | +50.4% |
| Profit (loss) for the period | 9904 | €80,687 | €92,467 | +€11,780 | +14.6% |
| Profit (loss) for the period to be appropriated | 9905 | €80,687 | €92,467 | +€11,780 | +14.6% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.